Appropriate Polypharmacy in Older People in Primary Care
Launched by QUEEN'S UNIVERSITY, BELFAST · Nov 26, 2019
Trial Information
Current as of August 25, 2025
Unknown status
Keywords
ClinConnect Summary
Design: We will perform a pilot cluster randomised controlled trial where 12 GP practices will be randomly assigned (6 GP practices per arm) to the intervention group versus usual care. Randomisation will be stratified according to location (Northern Ireland /Republic of Ireland - Cavan, Donegal, Leitrim, Louth, Monaghan and Sligo). GP practices will be randomly allocated to the intervention or usual care arm after patient screening and recruitment. A total of 120 patients (60 per study arm, approximately 10 patients, randomly selected, per GP practice) will be enrolled into the study.
Des...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients must be ≥70 years
- • Patients must be receiving four or more regular medicines
- • Patients must be resident in the community
- • Patients must be in receipt of a valid general medical services (GMS) card in the Republic of Ireland, or in the case of Northern Ireland patients, registered for NHS primary care services
- • Patients must be registered with and/or regularly attending the practice for a minimum of 12 months
- Exclusion Criteria:
- • Care home residents
- • Patients who are cognitively impaired
- • Patients with a terminal illness
- • Involved in other Investigational Medicinal Product (IMP) or medicines management studies
About Queen's University, Belfast
Queen's University Belfast is a prestigious research institution located in Northern Ireland, renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical research. The university actively engages in a diverse range of clinical trials, focusing on translational medicine and interdisciplinary collaboration to address pressing health challenges. With a strong emphasis on ethical standards and patient safety, Queen's University Belfast leverages its state-of-the-art facilities and a team of experienced researchers to contribute to the development of new therapies and enhance the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dublin, , Ireland
Belfast, Antrim, United Kingdom
Patients applied
Trial Officials
Carmel Hughes, PhD
Principal Investigator
Queen's University, Belfast
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials